Proxy Votes Now

Home › Funds › AQR › AQR Small Cap Multi-Style Fund

AQR Small Cap Multi-Style Fund (QSERX) proxy voting record 2025-2026

Fund family: AQR · Filed by AQR Funds (CIK 1444822) · SEC series S000040064

Share classes and tickers: QSERX (C000144291), QSMLX (C000124383), QSMNX (C000124384)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 4,367 with, 19 against, 0 abstentions (not counted as with management). Shareholder proposals: 12 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with AQR as a whole

The same two figures as AQR’s manager page (154,191 ballot items across 25 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsAQRItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.8%4,24493.7%128,774
Backed environmental and social shareholder proposals at US companiesn/a312.7%1,101

Where this fund voted differently from most AQR funds

Each ballot item this fund voted is set against the votes of the other AQR funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most AQR funds on all 159 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.8% of this fund’s 4,386 such votes could be given a sector; the other 185 (4.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance94000.0%
Consumer Discretionary91991.0%
Health Care64340.6%
Technology60610.2%
Industrials47330.6%
Energy24100.0%
Miscellaneous7600.0%
Real Estate6900.0%
Telecommunications6911.4%
Basic Materials6600.0%
Consumer Staples5411.9%
Utilities4500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,9914
Say-on-Pay5142
Audit-related4750
Compensation2020
Corporate Governance1258
Extraordinary Transactions630
Capital Structure461
Shareholder Rights and Defenses91
Diversity, Equity, and Inclusion11
Environment or Climate11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Qualys, Inc.June 10, 2026$3M60
Bloom Energy CorporationMay 21, 2026$2M80
Pediatrix Medical Group, Inc.May 7, 2026$1M120
Ironwood Pharmaceuticals, Inc.June 16, 2026$1M110
Amneal Pharmaceuticals, Inc.May 6, 2026$1M120
Universal Insurance Holdings, Inc.June 11, 2026$1M140
Sanmina CorporationMarch 9, 2026$1M121
Bumble Inc.June 4, 2026$1M50

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 30, 2026Ingles Markets, IncorporatedTo elect two directors to serve until the Company's 2027 annual meeting of shareholders and until their successors are duly elected and qualified: SUMMER ROAD NOMINEE: Rory A. Held Shareholder proposalForAgainst
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposalWithholdFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposalWithholdFor
May 12, 2026Group 1 Automotive, Inc.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalForAgainst
April 22, 2026Bloomin' Brands, Inc.Stockholder Proposal Regarding Disclosure of Employee Retention Demographics Shareholder proposalAgainstFor
April 22, 2026Bloomin' Brands, Inc.Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred Stock Shareholder proposalForAgainst
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalForAgainst
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 14, 2026Dine Brands Global, Inc.A stockholder proposal regarding the right of stockholders to call a special meeting of stockholders at a 15% ownership threshold. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

4,428 ballot items at 539 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, AQR Small Cap Multi-Style Fund (QSERX) voted at 539 shareholder meetings of 512 companies, on 4,428 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 19 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 17 shareholder proposals. It voted FOR the board's own proposals less often than AQR's funds as a whole (89.8% against 93.7%). It voted the same way as most AQR funds on every item where a comparison was possible. 4 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of AQR’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.